The European Union (EU) has been a long-standing and strategic partner of Gavi, contributing more than €3 billion (US$ 3.6 billion) since 2003 in support of immunisation programmes and stronger health systems worldwide. The partnership is built on a shared commitment to equitable access to vaccines, global health security and sustainable development. 

The European Union played a key role in supporting the Gavi COVAX AMC during the COVID-19 pandemic, providing €775 million (US$ 1.0 billion) in grant funding from 2020 through 2022; and working with the European Investment Bank (EIB) to mobilise additional financing and guarantees. This helped expand access to COVID-19 vaccines in low- and middle-income countries, strengthen global health security, and advance vaccine delivery and roll-out efforts. 

The EU has also played a leading role in supporting Gavi’s work to strengthen vaccine manufacturing capacity in Africa. In June 2024, the EU and its Member States announced support of more than €750 million (approximately US$ 864 million) for Gavi’s African Vaccine Manufacturing Accelerator (AVMA), including more than €200 million (approximately US$ 230 million) from the European Commission. 

At the Global Summit: Health & Prosperity through Immunisation in Brussels on 25 June 2025, co-hosted by the European Union and the Gates Foundation, the EU reaffirmed its previous commitment of €260 million (approximately US$ 299 million) announced at the 2024 UN General Assembly and made a total pledge of €360 million (approximately US$ 414 million) for the Gavi 6.0 strategic period (2026–2030). This formed part of a broader Team Europe pledge of more than €2 billion comprising contributions from the EU and its Member States.

The EU also supports Gavi through its partnership with the European Investment Bank (EIB), which has provided €600 million in surge financing and has since expanded to offer up to €1 billion in liquidity support for vaccine procurement and immunisation programmes, including emergency response needs.

Proceeds to Gavi 6.0 as of 30 June 2026†
Contributions to Gavi Board approved financing instruments

*Local currency

†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.

Contributions and pledges per strategic period (US$ millions)

Hover over the bar chart above to view the data

Direct Contributions (including Matching Fund)

Non-US$ contributions are converted to US$ as follows:

  • Before Gavi 6.0 (2000–2025): exchange rate on date of receipt; where hedged (2014–2025), the hedge rate applies instead.
  • Gavi 6.0 (2026 onward, received & future contributions and Matching Fund Pledges): Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

IFFIm Contributions

Non-US$ contributions are converted to US$ as follows:

  • Received Contributions: rate confirmed by the World Bank's International Bank for Reconstruction and Development (IBRD).
  • Future, signed contribution agreements: exchange rate at time of signing.
  • Future, unsigned contribution agreements: Bloomberg replenishment rate, 16:00 London time, 25 June 2025.

 

All donors